# Amol Deshpande

> Amol Deshpande is a seed investor at Frontera Health backing Health Care and Software. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Frontera Health](https://shizune.co/investors/profile/frontera-health)
- Location: San Francisco Bay Area, United States
- Total investments: 11
- Last investment: Apr 2024
- Lead investor: 18%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/amol-deshpande/1/4b8/236

Amol Deshpande is a seed investor at Frontera Health in San Francisco Bay Area focused on Health Care and Software. Amol Deshpande is based out of Denver, Colorado and is the Founder and CEO of Frontera Health. Amol previously worked at Farmer's Business Network as a Co-Founder and Shareholder.Amol Deshpande attended the University of Illinois Urbana-Champaign.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.5M–$4.3M |
| Series A | $15M–$16M |
| Series B | $6.3M–$22M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 27% |
| Software | 2 | 18% |
| Renewable Energy | 2 | 18% |
| B2B | 1 | 9% |
| Sales | 1 | 9% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 27% |
| Series A | 2 | 18% |
| Series B | 2 | 18% |
| Series C | 2 | 18% |
| Funding Round | 1 | 9% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 6 | 55% |
| Israel | 1 | 9% |
| Norway | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Greeneye Technology | Greeneye utilizes Artificial Intelligence to disrupt the agricultural pest control process, transitioning from the current practice of broadcast and wasteful spraying to precise and selective spraying of herbicides. Greeneye developed a proprietary selective spraying (SPP) system that turns every sprayer into a smart machine with seamlessintegration, Greeneye’s SSP system can detect weeds and spray them precisely in real-time, reducing up to 90% of herbicide usage. Demo - https://www.youtube.com/watch?v=iCOuTemX_cc&feature=youtu.beGreeneye is a leading technology company with a focus in precision agriculture, established in 2017 and based in Tel-Aviv, Israel. Greeneye has a multidisciplinary team with expertise in computer vision, artificial intelligence, agronomy, mechanical engineering, spraying applications, etc. We work with an extraordinary group of talented and visionary people who are committed to provide sustainable solutions for farmers around the world. | $20M | Venture - Series Unknown | Apr 17, 2024 |  |
| Linus Biotechnology | Linus Biotechnology develops a technology platform that builds on breakthroughs in exposome sequencing. The company was founded in 2020 by Manish Arora and is headquartered in New York, United States. | $16M | Series A | Jan 06, 2023 |  |
| Varos | Varos delivers the work of business analysts 10x faster, better, and cheaper using AI agents built for discovery.Most organizations rely on consultants, analysts, and countless meetings just to uncover knowledge their teams already have. Varos solves this by deploying AI agents that act as Senior Business Analysts—they talk to your teams throughbrief voice or text interviews, capture institutional knowledge, and analyze findings to deliver actionable insights.The information gathered is transformed into a secure, private knowledge base that organizations can use to assess current operations, capture business requirements, and share know-how across teams.In short, Varos helps companies uncover, understand, and use their own knowledge faster and more effectively | $4.3M | Seed | Feb 23, 2022 |  |
| Learnfully | Learnfully is a personalized online learning platform that provides recommendations and records progress toward goals. | $3M | Seed | Dec 08, 2021 |  |
| Opya | Opya is transforming autism care by successfully connecting treatment with technology. It is committed to the care and support of all individuals whose lives have been impacted by AutismThe company is a data-driven therapy platform designed to improve the effectiveness of the care we deliver. All being built to ensure families and clinicianshave the information they need to maximize their full potential. | $15.4M | Series A | Aug 18, 2021 |  |
| bttn | Wholesale medical supply platform | $1.5M | Seed | Jun 24, 2021 |  |
| Harvest Power | Harvest enables communities to produce renewable energy and high-value soil, mulch and organic fertilizer products from organic materials. The company harnesses the full potential of organic materials by recycling energy and nutrients back into local communities through its energy gardens and its production of nutrient-rich soils, mulches andfertilizers. Harvest owns and operates facilities throughout North America in British Columbia, Ontario, California and throughout the Mid-Atlantic, Midwest states and Northeastern US. | $110M | Series C | Apr 12, 2012 |  |
| Agilyx | We believe the time is right to expand advanced recycling, giving post-use plastic a new, circular life by converting this valuable material back into its original building blocks for reuse. By enabling plastic circularity on a global and commercial scale, we aim to play a vital role in accelerating the shift to a low-carbon economy. We haveco-founded Cyclyx International, Inc, a waste plastics management company, to work directly with industry participants to engineer customized plastic recovery programs that supply advanced and chemical recycling facilities. | $25M | Series C | Dec 19, 2011 |  |
| Harvest Power | Harvest enables communities to produce renewable energy and high-value soil, mulch and organic fertilizer products from organic materials. The company harnesses the full potential of organic materials by recycling energy and nutrients back into local communities through its energy gardens and its production of nutrient-rich soils, mulches andfertilizers. Harvest owns and operates facilities throughout North America in British Columbia, Ontario, California and throughout the Mid-Atlantic, Midwest states and Northeastern US. | $6.3M | Series B | May 24, 2011 |  |
| Agilyx | We believe the time is right to expand advanced recycling, giving post-use plastic a new, circular life by converting this valuable material back into its original building blocks for reuse. By enabling plastic circularity on a global and commercial scale, we aim to play a vital role in accelerating the shift to a low-carbon economy. We haveco-founded Cyclyx International, Inc, a waste plastics management company, to work directly with industry participants to engineer customized plastic recovery programs that supply advanced and chemical recycling facilities. | $22M | Series B | Mar 31, 2011 |  |

10 of 11 investments shown.

## Co-investors
- [Waste Management](https://shizune.co/investors/profile/waste-management) — VC Fund, 4 deals together
- [Jerusalem Venture Partners (JVP)](https://shizune.co/investors/profile/jerusalem-venture-partners) — VC Fund, 3 deals together
- [Chrysalix Venture Capital](https://shizune.co/investors/profile/chrysalix-energy) — VC Fund, 2 deals together
- [Deep Insight](https://shizune.co/investors/profile/deep-insight-6269) — VC Fund, 2 deals together
- [Generation Investment Management](https://shizune.co/investors/profile/generation-investment-management) — VC Fund, 2 deals together
- [Munich Venture Partners](https://shizune.co/investors/profile/munich-venture-partners) — VC Fund, 2 deals together

## About Frontera Health

VC Fund · Denver, United States

Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases.

2 contacts available at Frontera Health.

| Name | Title | Profile |
| --- | --- | --- |
| Amol Deshpande | Founder and CEO | https://shizune.co/investors/profile/amol-deshpande-2 |
| Bilal Zuberi | Member Board of Directors | https://shizune.co/investors/profile/bilal-zuberi |

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Agriculture (agtech) Angel Investors in Middle East](https://shizune.co/investors/agriculture-agtech-angel-investors-middle-east)
- [Agriculture (agtech) Angel Investors in Middle East](https://shizune.co/investors/agriculture-agtech-angel-investors-middle-east)
- [Big Data Angel Investors in Israel](https://shizune.co/investors/big-data-angel-investors-israel)
- [Agriculture (agtech) Angel Investors in Israel](https://shizune.co/investors/agriculture-agtech-angel-investors-israel)

## FAQ

### What does Amol Deshpande invest in?

Amol Deshpande invests primarily in Health Care, Software and Renewable Energy startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Amol Deshpande's check size?

Amol Deshpande typically joins rounds of $1.5M–$4.3M at Seed, $15M–$16M at Series A and $6.3M–$22M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Amol Deshpande participates in.

### When did Amol Deshpande last invest?

The most recent investment recorded for Amol Deshpande closed in Apr 2024. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co